Refractory Hyperlipidemia
1 clinical trials · Condition
◉ Watch Refractory Hyperlipidemia
| Record | Firm | Date |
|---|---|---|
| Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia (NCT06451770) | Verve Therapeutics, Inc. | 2024-10-30 |
Track Refractory Hyperlipidemia automatically
Every clearance here is in the API, with alerts when new ones post.